title: [Significance of type III serum N-terminal peptide procollagen assay in chronic viral hepatitis C].
abstract: The aim of this study was to evaluate the relationship between the serum N-terminal peptide of type III procollagen (PIIINP), Knodell's score and the response to treatment in 79 patients with viral C chronic hepatitis. Liver biopsy and serum PIIINP was assessed in all patients. Serum PIIINP was correlated with Knodell'score (r = 0.60; P = 10(-4)). Correlation between serum alanine amino-transferase and Knodell'score was smaller than for PIIINP (r = 0.38; P = 0.02). Forty-nine patients were treated with interferon alpha. A second biopsy and serum PIIINP determination were performed one year after treatment discontinuation. Means of serum PIIINP and Knodell'score significantly decreased after treatment (P < 0.01; P < 0.03). Among non-responder patients, serum PIIINP was initially more elevated: 37.5 +/- 12.6 ng/mL versus 22.6 +/- 3.8 (P < 10(-3)). Knodell's score decreased only among responder patients (P < 0.01 vs P < 0.7). Positive and negative predictive value for the response to treatment, evaluated by aminotransferases normalization, of serum PIIINP level < or = 24 ng/mL were 0.6 and 0.9 respectively. These findings suggest that serum PIIINP is a relevant marker of activity in patients with viral C chronic hepatitis and that it might have a predictive value of response to treatment.
authors.affiliation: Service d'Hépato-Gastroentérologie, Hôpital Jean-Verdier, Bondy.
authors.forename: D
authors.initials: D
authors.lastname: Pateron
authors.forename: D J
authors.initials: DJ
authors.lastname: Hartmann
authors.forename: W
authors.initials: W
authors.lastname: Berrebi
authors.forename: J C
authors.initials: JC
authors.lastname: Trinchet
authors.forename: H
authors.initials: H
authors.lastname: Jouanolle
authors.forename: P
authors.initials: P
authors.lastname: Callard
authors.forename: M
authors.initials: M
authors.lastname: Beaugrand
mesh_terms: D000328:Adult; D000368:Aged; D000410:Alanine Transaminase / Q000097:blood; D001706:Biopsy; D002908:Chronic Disease; D005260:Female; D006526:Hepatitis C / Q000097:blood* / Q000473:pathology / Q000628:therapy; D006801:Humans; D016898:Interferon-alpha / Q000627:therapeutic use; D008297:Male; D008875:Middle Aged; D010446:Peptide Fragments / Q000032:analysis*; D011347:Procollagen / Q000032:analysis*; D013997:Time Factors
chemical_list: D016898:Interferon-alpha; D010446:Peptide Fragments; D011347:Procollagen; C041876:procollagen Type III-N-terminal peptide; D000410:Alanine Transaminase
vernacular_title: Signification du dosage sérique du peptide N-terminal du procollagène de type III au cours des hépatites chroniques à virus C.